Chemoprevention of cancer

AS Tsao, ES Kim, WK Hong - CA: a cancer journal for clinicians, 2004 - Wiley Online Library
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical
agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The …

The role of vitamins in cancer: a review

AC Mamede, SD Tavares, AM Abrantes… - Nutrition and …, 2011 - Taylor & Francis
Vitamins are essential nutrients for human metabolism, playing an important role as
coenzymes or enzymes in many vital processes for the normal functioning of the body. In …

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from …

RJ Sylvester, APM Van Der Meijden, W Oosterlinck… - European urology, 2006 - Elsevier
OBJECTIVES: To provide tables that allow urologists to easily calculate a superficial bladder
cancer patient's short-and long-term risks of recurrence and progression after transurethral …

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic …

A Pawinski, R Sylvester, KH Kurth… - The Journal of …, 1996 - auajournals.org
Purpose: The use of prophylactic agents after primary resection can decrease the incidence
of tumor recurrence in patients with stage TaT1 bladder cancer. However, the long-term …

Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses

L Galluzzi, E Vacchelli, J Michels, P Garcia, O Kepp… - Oncogene, 2013 - nature.com
Abstract Pyridoxal-5′-phosphate (PLP), the bioactive form of vitamin B6, reportedly
functions as a prosthetic group for> 4% of classified enzymatic activities of the cell. It is …

Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer

P Royston, MKB Parmar, R Sylvester - Statistics in medicine, 2004 - Wiley Online Library
Many models for clinical prediction (prognosis or diagnosis) are published in the medical
literature every year but few such models find their way into clinical practice. The reason …

[HTML][HTML] Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach

A Leone, G Diorio, W Sexton, M Schell, M Alexandrow… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The clinical course for both early and late stage Bladder Cancer (BC) continues to be
characterized by significant patient burden due to numerous occurrences and recurrences …

Chemoprevention of cancer–focusing on clinical trials

T Kakizoe - Japanese journal of clinical oncology, 2003 - academic.oup.com
Chemoprevention of cancer is reviewed from the viewpoints of action mechanisms and
methodology of clinical trials in order to introduce promising agents discovered by in vitro …

Body mass index, diet-related factors, and bladder cancer prognosis: a systematic review and meta-analysis

E Westhoff, JA Witjes, NE Fleshner, SP Lerner… - Bladder …, 2018 - content.iospress.com
Background: Urologists are frequently confronted with questions of urinary bladder cancer
(UBC) patients about what they can do to improve their prognosis. Unfortunately, it is largely …

External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

V Hernández, E De La Peña, MD Martin… - World journal of …, 2011 - Springer
Purpose To perform an external validation of the EORTC risk tables and to evaluate their
applicability in the patients of our institution by comparing the actual risk of recurrence and …